We compared the results of the treatment of functioning SR adenomas using percutaneous ethanol injection (PEI) in 54 patients in the last four years and radiofrequency thermal ablation (RFTA) in 16 patients in the last one a half year.
P-557 TREATED ATHEROSCLEROTIC RENOVASCULAR HYPERTENSION IS A CORONARY HEART DISEASE EQUIVALENT
Survival in renovascular hypertension (RVH) is reduced compared to treated essential hypertension (EH), but how this compares to atherosclerotic disease in another vascular bed is not known. We compared allcause mortality among patients with successfully-treated RVH using angioplastyϮstents, and patients with EH who were extensively evaluated for coronary heart disease (CHD) from the same clinic during the same time period . These were subdivided into four groups: 14 with both RVH and CHD (age 68Ϯ6 years, 64% men, 36% white); 45 with RVH, but no CHD (age 61Ϯ11 years, 22% men, 56% white); 284 with CHD but no RVH (age 62Ϯ12 years, 43% men, 19% white), and 142 with neither (age 54Ϯ12 years, 37% men, 17% white). The index date was the date of diagnosis or exclusion of RVH or CHD, whichever came later. Following IRB approval, follow-up data about all-cause mortality was gathered by mailed questionnaire, telephone, or through the Social Security Death Index (mean possible follow-up: 14Ϯ2 years). Survival was compared by log-rank tests; Cox proportional hazards regression was used to adjust for baseline differences between groups. Mortality rates were are shown in the Table. Even after adjustment for baseline differences in age, gender, race/ethnicity, and initial systolic blood pressure, there were large and significant differences in survival between all groups except those with RVH (but no CHD) and those with CHD (but no RVH). These data suggest that treated renovascular hypertension has a prognosis no different than coronary heart disease, and should be considered a "CHD equivalent." Introduction: Spontaneous renal artery dissection (SRAD) is rare. Presentation varies from minimal symptomatology to life-threatening hypertension (HTN). Existing literature offers no consistent recommendations regarding the treatment of SRAD. We set out to analyze a case from our institution and case reports from the world literature in order to design diagnostic and treatment algorithms for SRAD.
Methods: A case of SRAD from our institution is presented. Additional 127 cases of SRAD from the world literature are included. Resulting findings were analyzed and diagnostic and treatment algorithms were designed.
Case Report: A 37-year old man presented with left flank pain and hematuria of 24 hours duration. Computed tomography (CT) of the abdomen was suspicious for left renal infarct. Magnetic resonance angiography (MRA) showed a focal lesion in a segmental branch of the left renal artery. Subsequent arteriography demonstrated an area of left renal artery dissection with aneurysmal dilatation of the adjacent segment. The patient recovered without sequelae after several days of inpatient observation.
Results: SRAD most frequently presents with a clinical triad of flank pain, hematuria and HTN. SRAD was more common in men (108/128). Mean patient age was 43.7 years. Initial diagnostic approach most often utilized a combination of intravenous pyelography (44/128), CT (15/ 128), ultrasonography (7/128), MRI./MRA. Arteriography constituted the most commonly used diagnostic modality (105/128). Treatment of SRAD centers around control of HTN and preservation of renal parenchyma. Non-operative treatment/clinical observation were sufficient in 38/128 of cases. Arterial bypass (intra-or extracorporeal) was the most commonly utilized surgical modality (50/128). Nephrectomy (28/128) was utilized in life-threatening emergencies, cases of profound renal parenchymal loss, and failed vascular bypass attempts. Endovascular techniques were used in 3/128 cases.
Conclusion: Early recognition and treatment of SRAD may be important to successful clinical outcome. Despite new imaging modalities, arteriography remains the gold standard for diagnosis of SRAD. Control of associated HTN is the main goal of medical treatment. Arterial bypass is indicated in cases of failed medical therapy. Partial or total nephrectomy is indicated in cases of significant renal parenchymal damage with concurrent severe HTN. 
